SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marico gains on extending healthy foods portfolio

29 Sep 2021 Evaluate

Marico is currently trading at Rs. 553.00, up by 2.15 points or 0.39% from its previous closing of Rs. 550.85 on the BSE.

The scrip opened at Rs. 559.80 and has touched a high and low of Rs. 559.80 and Rs. 547.60 respectively. So far 38629 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 587.25 on 13-Sep-2021 and a 52 week low of Rs. 346.00 on 26-Oct-2020.

Last one week high and low of the scrip stood at Rs. 572.65 and Rs. 545.90 respectively. The current market cap of the company is Rs. 71870.80 crore.

The promoters holding in the company stood at 59.61%, while Institutions and Non-Institutions held 34.64% and 5.76% respectively.

With an aim to further strengthen its presence in the immunity-boosting and ayurvedic segment, Marico has extended its healthy foods portfolio with the launch of Saffola Chyawanprash under Immuniveda banner, its contemporary Ayurvedic range.

Adding to the success of brand Saffola in immunity boosting space, this new offering by Marico provides the power of Ayurveda to its consumers with the use of modern technology, under the renowned expertise that the Saffola aegis is trusted for.

Marico is one of India’s leading Consumer Products Group, in the global beauty and wellness space. Its products are sold in India and about 25 other countries in Asia and Africa.

Marico Share Price

831.70 -0.35 (-0.04%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
AWL Agri Business 206.65
Patanjali Foods 462.10
Gokul Agro Resources 238.35
Marico 831.70
BCL Industries 35.98
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×